JasonLamarAldredMD

PubMed

• 17 citations
  Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.
  Jason Aldred, Eric Freire-Alvarez, Alexander V Amelin, Angelo Antonini, Bruno Bergmans
  Neurology and Therapy. 2023-12-01
• 19 citations
  Non-invasive MRI quantification of cerebrospinal fluid dynamics in amyotrophic lateral sclerosis patients.
  Lucas R. Sass, Mohammadreza Khani, Jacob Romm, Marianne Schmid Daners, Kyle McCain
  Fluids and Barriers of the CNS. 2020-01-21
• 141 citations
  National randomized controlled trial of virtual house calls for Parkinson disease.
  Christopher A. Beck, Denise B. Beran, Kevin M. Biglan, Cynthia M. Boyd, E. Ray Dorsey
  Neurology. 2017-09-12

Journal Articles

• The past, present, and future of telemedicine for Parkinson's disease  
  Achey, M, Aldred, JL et al., Movement Disoders, 6/29/2014
• Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease  
  Aldred JL, Brod LS, Nutt JG, Movement Disorders, 5/2012

Books/Book Chapters

• Encyclopedia of Movement Disorders 
  Chapter: Levodopa. 
  Page 132 - 137Aldred, J. and Nutt, J.Editors: K. Kompoliti and L. Verhagen.Associated Press2010

Abstracts/Posters

• Levodopa-Carbidopa Intestinal Gel for the Treatment of Motor Fluctuations and Dyskinesia in Patients with Advanced Parkinson's Disease in a Real World Setting: Results...
  Standaert, D, Aldred, J et. al, XXIV World Congress of Neurology, Dubai, UAE, 7/2019
• Open Label Study of Pimavanserin in Patients with Comorbid Parkinson's Disease and Depression.
  Guskey, M, Aldred, J et al., Neuroscience Education Institute Congress, Colorado Springs, CO, USA, 2019
• Medication Use and In-Hospital Complications for Patients with Parkinson’s disease: A Retrospective Review. (Poster Presentation)
  Kerndt, T, Aldred J, et al., World Parkinson Congress, Montreal, Canada, 1/1/2013
• Hyperkinetic shoulder movement disorder associated with Ehlers-Danlos Syndrome. (Abstract)
  American Academy of Neurology Meeting, 1/1/2009
• Writer’s cramp, hemidystonia and ataxia secondary to pontomedullary tumor. (Abstract)
  Movement Disorders Society International Congress, 1/1/2008
• Efficacy of donepezil for tic reduction. (Abstract)
  Movement Disorders Society International Congress, 1/1/2008
• Join now to see all

Lectures

• DBS Update 
  La Crosse, WI - 1/1/2013
• Advances in Parkinson’s Care and Treatment 
  Wisconsin Dells, WI - 1/1/2013
• “Patient with Limited Response to Previous Toxin Therapies” 
  La Crosse, WI - 1/1/2012
• “Update on Dystonia and Movement Disorders” 
  La Crosse, WI - 1/1/2012
• Understanding Gait in Parkinson’s Disease 
  1/1/2012
• Second Annual Parkinson’s Symposium 
  La Crosse, WI - 1/1/2012
• Movement Disorders Presentation 
  1/1/2011
• Parkinson’s Disease Update 
  Black River Falls, WI - 1/1/2011
• First Annual Parkinson’s Symposium 
  La Crosse, WI - 1/1/2011
• Parkinson’s Disease Research Update 
  1/1/2010
• “Cervical Dystonia” 
  1/1/2010
• “Movement Disorders”, Grand Rounds 
  Gundersen Lutheran Medical Center - 1/1/2010
• “Early Diagnosis and Treatment of Parkinson’s Disease - A Continuing Pursuit” 
  Gundersen Lutheran Medical Center - 1/1/2010
• “Shaking Up Parkinson’s Disease” 
  Tomah, WI - 1/1/2010
• Parkinson’s Disease Update 
  Decorah, IA - 1/1/2010
• Essential Tremor Patient Symposium 
  Gundersen Lutheran Medical Center, La Crosse, WI - 1/1/2010
• Research Update on Parkinson’s Disease 
  1/1/2008
• Non-Motor Features of Parkinson’s Disease, presentation 
  1/1/2007
• Spinal Cord Disease, presentation 
  1/1/2006
• Update of Parkinson’s Disease Research for the Corvallis 
  1/1/2006
• Neurotoxicology and Movement Disorders, presentation 
  1/1/2005
• Join now to see all

Other

• Concept and Development of Department of Neurology and Residency Program Website 
  Aldred JL, Oregon Health and Science Neurology Department
  1/1/2005